NEW YORK (GenomeWeb News) – WaferGen Biosystems today reported third-quarter revenues of $633,000, compared to $79,000 for the third quarter of 2009, as a result of its recently launched SmartChip system.

The Fremont, Calif.-based firm, which launched its SmartChip Real-Time PCR System in August, said that the majority of its revenues for the quarter came from the sales of systems, SmartChips, and gene-expression profiling services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.